A recent study revealed that intermittent fasting may assist patients accomplish long-term remission from Crohn’s disease.
A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.
We often treat intestinal infections as an episode: a few days of symptoms, elimination of the pathogen, and recovery. In ...
SHANGHAI, Feb 11 (Reuters) - Eli Lilly has won Chinese regulators' approval for its drug to treat chronic inflammatory bowel ...
Inflammatory bowel disease (IBD) is an umbrella term for a group of chronic conditions that cause inflammation and swelling ...
For the estimated 5 million people worldwide living with inflammatory bowel disease, finding relief from debilitating symptoms often feels like an endless journey through medication trials and ...
News and commentary from the world of gastroenterology and hepatology ...
Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, ...